A carregar...

Gemcitabine resistance in triple-negative breast cancer cells can be reverted by Drosophila melanogaster deoxyribonucleoside kinase in the nucleus or cytosol

The development of drug resistance to chemotherapeutic agents has consistently presented a challenge in terms of the treatment of patients with triple-negative breast cancer (TNBC). In the present study, gemcitabine (dFdC)-resistant TNBC cells were established, and the effects of lentivirus-deoxyrib...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Zhao, Yan, Jiang, Haiyang, Gu, Ming, Zu, Cong, Zheng, Xinyu
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7509507/
https://ncbi.nlm.nih.gov/pubmed/32973960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.12109
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!